ImmunityBio, Inc.
For the period ended Dec 31, 2025. Filed Feb 23, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 23, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
We lease property in multiple facilities across the U.S. and Italy, including facilities located in El Segundo and Culver City, CA that are leased from related parties. See Note 15 “Related-Party Agreements” of the “Notes to Consolidated Financial Statements” that appears in Part II, Item 8. “Financial Statements and Supplementary Data” of this Annual Report for more information about our related-party leases.
The following table summarizes our principal properties under lease as of December 31, 2025:
| Location | Expiration Year (1) | ApproximateRentableSquare Feet (2), (3) | Primary Function(s) |
|---|---|---|---|
| United States | |||
| Dunkirk, NY | 2028 | 409,000 | Future Manufacturing Facility |
| El Segundo, CA | 2026 – 2029 | 132,136 | Laboratory – Research & Manufacturing |
| Louisville, CO | 2030 | 50,838 | Laboratory – Research |
| Culver City, CA | Month to Month | 46,330 | Laboratory – Research & Manufacturing |
| San Diego, CA | 2030 | 44,681 | Laboratory – Research & Corporate Office |
| Summit, NJ | 2028 | 11,256 | Office – Regulatory Affairs |
| International | |||
| Italy | 2027 – 2030 | 15,748 | Laboratory – Research & Office |
| (1) | Expiration years shown are per the lease agreements in effect as of December 31, 2025 and do not reflect contractual options to extend the term of the lease available to us under the lease agreements. For locations with multiple leases, the first and last expiration year are shown. |
| (2) | Amounts shown represent the total approximate rentable square feet for all buildings located in each city. |
| (3) | Previous lease for laboratory and research space in Seattle, WA expired in 2025. We will occupy space in 2026 under a new lease. |
We believe that our existing facilities are adequate to meet our current and future needs and that we will be able to renew existing leases and obtain additional commercial space as needed.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.